WealthStone’s Cardinal Health CAH Stock Holding History

WealthStone’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-809	Closed	-$38.1K	–	145
2019 Q2	$38.1K	Buy	+809	New	+$37.3K	0.02%	195

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WealthStone's CAH Position: Q3 2019 in Review

WealthStone sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 809 shares — an estimated $38.1K sold.

WealthStone first reported a position in CAH in Q2 2019 and held it in 1 quarter. The position peaked at $38.1K in Q2 2019. 663 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

WealthStone reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
WealthStone sold 809 Cardinal Health shares in Q3 2019, an estimated $38.1K.
WealthStone first reported a position in Cardinal Health in Q2 2019 and held it in 1 quarter.
WealthStone's Cardinal Health position peaked at $38.1K in Q2 2019.
663 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.